| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $38.2M | — | +316.9% |
| R&D Expense | $47.4M | — | +16.8% |
| SG&A Expense | $22.1M | — | +20.4% |
| Operating Income | -$31.3M | — | +37.2% |
| Pre-tax Income | -$26.1M | — | +44.4% |
| Income Tax | $0 | — | — |
| Net Income | -$26.1M | — | +44.4% |
| EPS (Basic) | -$0.13 | — | +55.2% |
| EPS (Diluted) | -$0.13 | — | +55.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $544.6M | -9.5% | +124.0% |
| Accounts Receivable | $0 | -100.0% | — |
| Current Assets | $561.3M | -8.7% | +117.6% |
| Total Assets | $583.5M | -8.6% | +102.4% |
| Current Liabilities | $49.8M | -47.6% | -43.0% |
| Total Liabilities | $71.8M | -36.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$59.6M | — | +5.5% |
| Capital Expenditures | $438K | — | +165.5% |
| Investing Cash Flow | -$438K | — | -165.5% |
| Financing Cash Flow | $2.5M | — | -39.2% |
| Free Cash Flow | -$60.0M | — | +5.1% |
| -33.9% |
| Stockholders' Equity | $511.7M | -1.3% | +197.9% |